Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial designed to quantify the immune response and determine the
tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for
patients with advanced prostate cancer.